封面
市场调查报告书
商品编码
1609169

下一代定序 CLIA 实验室服务市场:按技术、验证类型、应用和最终用户 - 2025-2030 年全球预测

Next Generation Sequencing CLIA Laboratory Services Market by Technology, Certificate Types, Application, End-users - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年下一代定序CLIA实验室服务市场规模为58.1亿美元,预计2024年将达到67.8亿美元,复合年增长率为13.97%,2030年将达到145.2亿美元,预计将达到1000万美元。

次世代定序(NGS) CLIA化验服务是临床诊断的重要领域,它将最先进的定序技术与严格的实验室标准结合。 CLIA(临床实验室改进修正案)认证确保这些实验室符合高品质的检测通讯协定,从而确保患者检测结果的准确性、可靠性和及时性。 NGS CLIA化验服务的需求在于提供全面的基因定序的能力,以支持早期疾病检测、个人化医疗以及针对个人基因图谱量身定制的治疗策略。其应用范围包括癌症基因组、遗传疾病检测、感染疾病分析和药物基因组学。典型的最终用户包括医院、学术研究机构、诊断实验室和製药公司。显着的市场成长驱动因素包括遗传疾病和癌症盛行率上升、NGS 技术进步带来的成本降低以及个人化医疗需求的增加。最近的机会包括将人工智慧用于基因组学资料分析、扩展到农村和服务不足的医疗保健环境,以及透过战略伙伴关係关係渗透国际市场。然而,与基因检测相关的伦理问题、设备和营运成本较高的初始投资以及严格的法规环境等因素对市场成长构成了挑战。此外,资料隐私问题和报销限制仍然是重大障碍。儘管如此,创新和研究的最佳领域包括开发更有效率的生物资讯工具和平台、提高定序准确性和速度以及探索非侵入性检测方法。此外,跨部门伙伴关係有可能扩大 NGS 在新治疗领域的效用。该市场的特点是技术进步快、竞争激烈,需要持续创新和策略行销才能有效获得和维持市场占有率。为了在这个充满活力的环境中蓬勃发展,我们鼓励公司投资研发、策略联盟,并提供丰富的服务组合,以满足广泛的医疗保健需求。

主要市场统计
基准年[2023] 58.1亿美元
预测年份 [2024] 67.8亿美元
预测年份 [2030] 145.2亿美元
复合年增长率(%) 13.97%

市场动态:快速发展的下一代定序 CLIA 实验室服务市场的关键市场洞察

供需的动态交互作用正在改变下一代定序 CLIA 实验室服务市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 传染性和非传染性疾病的迅速增加以及对诊断测试的需求
    • 越来越多的政府专注于加强疾病筛检和监测能力
    • 增加对癌症研究的研究和投资
  • 市场限制因素
    • 诊断中心缺乏熟练的专业人员
  • 市场机会
    • 利用 NGS 提高基因组分析的临床效用与有效性
    • 新一代定序技术的技术进步
  • 市场挑战
    • 生物资讯学和计算技术的复杂性不断增加

波特五力:引领次世代定序 CLIA 实验室服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战,以确保更强大的市场地位。

PESTLE分析:了解下一代定序 CLIA 实验室服务市场的外部影响

外部宏观环境因素在塑造下一代定序 CLIA 实验室服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解下一代定序 CLIA 实验室服务市场的竞争格局

下一代定序 CLIA 实验室服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵次世代定序 CLIA 实验室服务市场供应商的绩效评估

FPNV 定位矩阵是评估下一代定序 CLIA 实验室服务市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了下一代定序 CLIA 实验室服务市场的成功之路

下一代定序 CLIA 实验室服务市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 传染性和非传染性疾病的增加以及对诊断测试的需求
      • 政府专注于加强疾病检测和监测能力
      • 增加对癌症研究的研究和投资
    • 抑制因素
      • 诊断中心缺乏熟练的专业人员
    • 机会
      • 利用 NGS 提高基因组分析的临床效用与有效性
      • 次世代定序技术的技术进步
    • 任务
      • 生物资讯学和技术中的计算复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 下一代定序 CLIA 实验室服务市场:依技术分类

  • 游离DNA定序
  • 元基因组定序
  • NGS基因组定序
  • 标靶定序和定序
  • 全EXOME定序
  • 全基因组序列分析

第 7 章按证书类型分類的下一代定序 CLIA 实验室服务市场

  • 医护人员进行的显微镜检查证明
  • 证书
  • 合格证书
  • 註册证书
  • 豁免证明书

第 8 章下一代定序 CLIA 实验室服务市场:依应用分类

  • 生物标记发现
  • 诊断
  • 药物发现
  • 精准医疗

第 9 章 下一代定序 CLIA 实验室服务市场:按最终用户

  • 诊断中心
  • 医院

第 10 章 美洲次世代定序 CLIA 实验室服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区次世代定序CLIA实验室服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的下一代定序 CLIA 实验室服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • Beijing Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Charles River Laboratories, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • NanoString Technologies, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Pillar Biosciences, Inc.
  • Qiagen NV
  • Saphetor SA
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-C41945B3D381

The Next Generation Sequencing CLIA Laboratory Services Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.78 billion in 2024, and is projected to grow at a CAGR of 13.97%, to USD 14.52 billion by 2030.

Next Generation Sequencing (NGS) CLIA Laboratory Services represent a pivotal area in clinical diagnostics, combining cutting-edge sequencing technologies with rigorous laboratory standards. The Clinical Laboratory Improvement Amendments (CLIA) certification ensures that these labs meet high-quality testing protocols, thereby assuring accuracy, reliability, and timeliness of patient test results. The necessity of NGS CLIA lab services lies in their ability to offer comprehensive genetic sequencing that aids in early disease detection, personalized medicine, and treatment strategies tailored to individual genetic profiles. Their application spans cancer genomics, hereditary disease testing, infectious disease analysis, and pharmacogenomics. Key end-users include hospitals, academic research institutes, diagnostic laboratories, and pharmaceutical companies. Notably, factors driving market growth include the rising prevalence of genetic disorders and cancer, advancements in NGS technology reducing costs, and the increasing demand for personalized medicine. Recent opportunities highlight the integration of artificial intelligence for data analytics in genomics, expansion into rural and underserved healthcare settings, and international market penetration through strategic partnerships. However, market growth is challenged by factors such as ethical concerns related to genetic testing, significant initial investment for equipment and operational costs, and a stringent regulatory environment. Furthermore, data privacy issues and reimbursement constraints remain salient barriers. Nonetheless, the best areas for innovation and research include developing more efficient bioinformatics tools and platforms, improving sequencing accuracy and speed, and exploring non-invasive testing methods. Additionally, cross-disciplinary partnerships could expand the utility of NGS in new therapeutic areas. The market is characterized by rapid technological advancements and intense competition, necessitating continuous innovation and strategic marketing to capture and retain market share effectively. Companies are advised to invest in R&D and strategic collaborations to excel in this dynamic environment, offering enriched service portfolios that cater to a broad array of healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 5.81 billion
Estimated Year [2024] USD 6.78 billion
Forecast Year [2030] USD 14.52 billion
CAGR (%) 13.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Sequencing CLIA Laboratory Services Market

The Next Generation Sequencing CLIA Laboratory Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
    • Increasing government focus on enhancing disease screening and monitoring capabilities
    • Rising research and investments in cancer research
  • Market Restraints
    • Limited availability of skilled professionals in diagnostic centers
  • Market Opportunities
    • Improvements in clinical utility and efficacy of genomic profiling with the NGS
    • Technological advances in next generation sequencing technologies
  • Market Challenges
    • Bioinformatics and computational complications in technology

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Sequencing CLIA Laboratory Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Sequencing CLIA Laboratory Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Sequencing CLIA Laboratory Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Sequencing CLIA Laboratory Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Sequencing CLIA Laboratory Services Market

A detailed market share analysis in the Next Generation Sequencing CLIA Laboratory Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Sequencing CLIA Laboratory Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Sequencing CLIA Laboratory Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next Generation Sequencing CLIA Laboratory Services Market

A strategic analysis of the Next Generation Sequencing CLIA Laboratory Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing CLIA Laboratory Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, Beijing Genomics Co. Ltd., Bio-Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina, Inc., Macrogen, Inc., NanoString Technologies, Inc., Perkin Elmer, Inc., PierianDx, Inc., Pillar Biosciences, Inc., Qiagen N.V., Saphetor SA, Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing CLIA Laboratory Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cell Free DNA Sequencing, Metagenomic Sequencing, NGS Gene Panel Sequencing, Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Certificate Types, market is studied across Certificate for Provider-Performed Microscopy Procedures, Certificate of Accreditation, Certificate of Compliance, Certificate of Registration, and Certificate of Waiver.
  • Based on Application, market is studied across Biomarker Discovery, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End-users, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
      • 5.1.1.2. Increasing government focus on enhancing disease screening and monitoring capabilities
      • 5.1.1.3. Rising research and investments in cancer research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals in diagnostic centers
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in clinical utility and efficacy of genomic profiling with the NGS
      • 5.1.3.2. Technological advances in next generation sequencing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Bioinformatics and computational complications in technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next Generation Sequencing CLIA Laboratory Services Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell Free DNA Sequencing
  • 6.3. Metagenomic Sequencing
  • 6.4. NGS Gene Panel Sequencing
  • 6.5. Targeted Sequencing & Re-sequencing
  • 6.6. Whole Exome Sequencing
  • 6.7. Whole Genome Sequencing

7. Next Generation Sequencing CLIA Laboratory Services Market, by Certificate Types

  • 7.1. Introduction
  • 7.2. Certificate for Provider-Performed Microscopy Procedures
  • 7.3. Certificate of Accreditation
  • 7.4. Certificate of Compliance
  • 7.5. Certificate of Registration
  • 7.6. Certificate of Waiver

8. Next Generation Sequencing CLIA Laboratory Services Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarker Discovery
  • 8.3. Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Precision Medicine

9. Next Generation Sequencing CLIA Laboratory Services Market, by End-users

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals

10. Americas Next Generation Sequencing CLIA Laboratory Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Next Generation Sequencing CLIA Laboratory Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Next Generation Sequencing CLIA Laboratory Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Azenta Life Sciences
  • 3. Beijing Genomics Co. Ltd.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioMerieux S.A.
  • 6. Charles River Laboratories, Inc.
  • 7. Eurofins Scientific SE
  • 8. F. Hoffmann-La Roche AG
  • 9. Illumina, Inc.
  • 10. Macrogen, Inc.
  • 11. NanoString Technologies, Inc.
  • 12. Perkin Elmer, Inc.
  • 13. PierianDx, Inc.
  • 14. Pillar Biosciences, Inc.
  • 15. Qiagen N.V.
  • 16. Saphetor SA
  • 17. Takara Bio Inc.
  • 18. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 196. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023